Poseida Therapeutics, Inc.
PSTXDelisted Jan 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001661460
Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Poseida Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 89 | 1 | 102 | +14 |
| Shares | 43.0M | 1.07K | 44.1M | +1.08M (+2.5%) |
| Value | $227.6M | $5.67K | $136.0M | −$91.6M (−40.3%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (28)
Institutions that held Poseida Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (14)
Institutions that held Poseida Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Bank of Montreal | 399,472 | $1.62M |
| Invesco Ltd. | 290,349 | $1.54M |
| EAM Investors, LLC | 218,305 | $1.16M |
| Walleye Capital LLC | 64,371 | $341.2K |
| Mirabella Financial Services LLP | 18,385 | $97.4K |
| Lighthouse Investment Partners, LLC | 17,319 | $91.8K |
| Arrowstreet Capital, Limited Partnership | 15,975 | $85.0K |
| Prudential Financial Inc | 12,600 | $66.8K |
| Walleye Trading LLC | 10,827 | $57.4K |
| State of Wyoming | 7,146 | $37.9K |
| Group One Trading, L.P. | 2,986 | $15.8K |
| Aquatic Capital Management LLC | 1,400 | $7.00K |
| Money Concepts Capital Corp | 325 | $1.72K |
| Signaturefd, LLC | 211 | $1.12K |
Not filed for Q1 2023 yet (1)
Institutions that held Poseida Therapeutics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| HealthInvest Partners AB | 1,069 | $5.67K |